Published on in Vol 6, No 3 (2022): March
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/29154, first published
.
1 Novaris Institutes for Biomedical Research, Cambridge, MA, United States
2 Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States
3 Pear Therapeutics, Boston, MA, United States